And Here's Why
Given that use of GLP-1 RAs have been associated with muscle loss, an important question that remains is whether repeated GLP-1 RA use and cessation alter body composition in favour of fat mass relative to lean mass, pushing individuals with obesity closer to sarcopenic obesity
Typical stacking protocols run both peptides concurrently during the same 10 to 20 day cycle, with thymalin administered at 5 to 10 mg daily via intramuscular or subcutaneous injection
Jouffe C et al (2022) Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease
Serena C, Ceperuelo-Mallafr V, Keiran N, Queipo-Ortuo MI, Bernal R, Gomez-Huelgas R, Urpi-Sarda M, Sabater M, Prez-Brocal V, Andrs-Lacueva C, Moya A, Tinahones FJ, Fernndez-Real JM, Vendrell J, Fernndez-Veledo S
Impaired glutathione synthesis in neurodegeneration